In animals and in man, diverse immunologic functions are mediated by specialized T-cell (thymus-derived lymphocyte) subsets that are distinguishable from one another on the basis of differences in cell surface determinants. Unfortunately, in humans, subset-specific antibodies have been difficult to generate. In this study, production of a murine monoclonal antibody specific for a subset of human T cells was achieved by fusing a sensitized B cell (bone marrow-derived cell) with a myeloma cell and isolating the antibody secreted by the resultant hybrid clone. This antibody binds 30-35% of peripheral T lymphocytes (T(a) (+) cells) but fails to bind remaining T lymphocytes (T(a) (-) cells), B lymphocytes, or monocytes. T(a) (+) and T(a) (-) subpopulations were separated with a fluorescence-activated cell sorter and their in vitro responses to various stimuli were assessed. T(a) (+) and T(a) (-) cells respond equally well to soluble antigens, allogeneic B cells, and autologous B cells, but only T(a) (+) cells respond to concanavalin A. T(a) (+) cells cultured in the presence of concanavalin A gradually lose the T(a) marker, an effect not observed after stimulation with phytohemagglutinin, soluble antigens, or alloantigens. These results suggest that the functional subpopulation of T cells defined by T(a) does not correspond to any previously described human T cell subset. Furthermore, somatic cell hybridization has been shown to be a feasible method for production of monoclonal antibodies specific for subpopulations of human lymphocytes.
No takes yet. Share an insight, caveat, or question.
Engleman et al. (1980) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: